Description
Dr. Lal PathLabs Limited has fixed December 19, 2025 as record date for bonus issue of 1 equity share for every 1 existing share held, with deemed allotment on December 22, 2025.
Summary
Dr. Lal PathLabs Limited (Scrip Code: 539524/139524) has confirmed the record date of December 19, 2025 for issuing bonus equity shares in the ratio of 1:1. The company will issue 83,775,510 bonus equity shares of Rs. 10/- each, with deemed allotment on December 22, 2025 and trading commencing on December 23, 2025. The company has obtained In-Principle Approval from BSE and uploaded the Scrutinizer’s Report as required.
Key Points
- Bonus ratio: 1 new equity share for every 1 existing equity share held
- Face value: Rs. 10/- per share
- Total bonus shares to be issued: 83,775,510 equity shares
- ISIN: INE600L01024
- In-Principle Approval obtained from BSE
- Scrutinizer’s Report uploaded 3 working days before record date
- Bonus shares will be credited by 12 PM on deemed allotment date
- Distinctive number range: 83775511 to 167551020
Regulatory Changes
No regulatory changes introduced by this circular.
Compliance Requirements
- Company undertakes to credit bonus shares to beneficiary accounts by 12 PM on December 22, 2025
- Scrutinizer’s Report has been uploaded on BSE Listing Centre as required
- In-Principle Approval already obtained from BSE
- Compliance with all pre-requisites for bonus issue completion
Important Dates
- Record Date: Friday, December 19, 2025
- Deemed Date of Allotment: Monday, December 22, 2025 (credit by 12 PM)
- Effective Listing Date: Tuesday, December 23, 2025 (trading commences)
Impact Assessment
Market Impact: High impact corporate action that will double the outstanding equity shares of Dr. Lal PathLabs. The 1:1 bonus ratio is highly favorable for existing shareholders.
Shareholder Impact: All shareholders on record as of December 19, 2025 will receive one additional share for each share held, effectively doubling their shareholding without any cash outflow.
Liquidity Impact: Expected to improve stock liquidity and affordability as the share price will adjust post-bonus, potentially attracting more retail investors.
Operational Impact: The issuance of 83,775,510 new shares will significantly increase the company’s equity base and improve free float if applicable.
Impact Justification
Significant corporate action affecting all shareholders with 1:1 bonus ratio, doubling outstanding shares. High impact on liquidity and shareholding structure.